The Importance of Cellular Senescence in Frailty and Cardiovascular Diseases

Adv Exp Med Biol. 2020:1216:79-86. doi: 10.1007/978-3-030-33330-0_9.

Abstract

Frailty is a complex clinical syndrome, progressively described in the last thirty years, resulting from multiple impairments across many organs and systems and characterized by a reduction in physiological reserves and increased vulnerability to stressors, as well. Cardiovascular diseases (CVDs) are a common health problem in very old populations. Age-related changes occur throughout the body and in all organs, including the cardiovascular system. Cellular senescence links age-related CVDs and frailty by many mechanisms of particular interest in the aging biology and geriatric syndromes. Cellular senescence may represent the pivotal factor with its senescence-associated secretory phenotype (SASP) leading to systemic inflammation. In this context, SASP may represent the key element in the association between aging, frailty and the development of age-related CVDs.

Keywords: Aging; Cardiovascular; Comorbidities; Frailty; Inflammation; Senescence.

Publication types

  • Review

MeSH terms

  • Aged
  • Aging / pathology*
  • Cardiovascular Diseases / complications*
  • Cardiovascular Diseases / pathology*
  • Cellular Senescence*
  • Frail Elderly*
  • Frailty / complications*
  • Frailty / pathology*
  • Humans
  • Inflammation / complications
  • Inflammation / pathology